Inicio>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Enniatin A1

Enniatin A1

Catalog No.GC43610

La enniatina A1 aislada de las micotoxinas de Fusarium es un hexadepsipéptido cÍclico que consta de Ácidos D-α-hidroxiisovalérico alternados y N-metil-L-aminoÁcidos. Enniatin A1 posee propiedades anticancerÍgenas mediante la inducciÓn de apoptosis y la interrupciÓn de la vÍa de seÑalizaciÓn de ERK. Enniatin A1 inhibe ACAT con un IC50 de 49 μM en microsomas de hÍgado de rata.

Products are for research use only. Not for human use. We do not sell to patients.

Enniatin A1 Chemical Structure

Cas No.: 4530-21-6

Tamaño Precio Disponibilidad Cantidad
1mg
231,00 $
Disponible
5mg
984,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Enniatins are cyclohexadepsipeptides commonly isolated from fungi that are known to have antibiotic properties and to induce apoptosis in several cancer lines. Many function as ionophores, forming pores in cellular membranes to allow selective ion transport. Enniatin A1 is one of four major analogs in the enniatin complex . Its ionophoric activity has been described. Additionally, enniatin A1 has been found to induce apoptosis in cancer cells (EC50 = 5 µM in H4IIE rat hepatoma cells), decreasing the activation of the cell proliferation kinase, ERK (p44/p42) and inhibiting TNF-α-induced NF-κB activation.

Reseñas

Review for Enniatin A1

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Enniatin A1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.